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Abstract
A novel antimicrobial peptide was isolated and characterized from the earthworm, Lumbricus rubellus. The antimicrobial
peptide was purified to homogeneity by a heparin-affinity column and C18 reverse-phase HPLC, and named lumbricin I.
Lumbricin I was a proline-rich antimicrobial peptide of 62 amino acids (15% proline in molar ratio; molecular mass,
7231 Da), whose complete sequence was determined by a combination of peptide sequence and cDNA analysis. The peptide
and cDNA sequence analysis revealed that lumbricin I was produced as a precursor form consisting of 76 amino acids, with
14 residues in a presegment and 62 residues in mature lumbricin I. Lumbricin I showed antimicrobial activity in vitro against
a broad spectrum of microorganisms without hemolytic activity. In addition, a 29-amino acid peptide, named lumbricin I(6^
34), which was derived from residues 6^34 of lumbricin I, showed marginally stronger antimicrobial activity than lumbricin I.
Northern blot analysis on total RNA revealed that expression of lumbricin I gene was not induced by bacterial infection, but
was constitutively expressed. Furthermore, the expression of lumbricin I gene was specific in adult L. rubellus : Lumbricin I
mRNA was detected only in adult L. rubellus, but not in eggs and young L. rubellus. ß 1998 Elsevier Science B.V. All
rights reserved.
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1. Introduction
In recent years, antimicrobial peptides have be-
come recognized as important contributors to non-
speci¢c host defense for both vertebrates and inver-
tebrates. The value of antimicrobial peptides lies in
their ease and speed of synthesis, their broad specif-
icity against prokaryotic cells and their general lack
of toxicity for eukaryotic hosts [1]. Thus, they serve
as a ¢rst-line defense against microbial invasion, sup-
plementing the host’s humoral and cellular immune
system. Many di¡erent kinds of antimicrobial pepti-
des, which possess antimicrobial activity against bac-
teria, fungi and enveloped viruses with little or no
cytolytic activity, have been isolated from diverse
sources [1,2]. Most of these peptides, although a
few non-cationic antimicrobial peptides have been
recently characterized [3,4], share the property of
being cationic, but otherwise di¡er considerably in
basic features, such as their size, the presence of di-
sul¢de bonds and structural motifs [5]. These pepti-
des have been shown to exert their antimicrobial ac-
tivities through either the lipid bilayer of the cell
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membrane by the formation of multimeric pores [6]
or the interaction with DNA or RNA after penetrat-
ing into the cell membranes [7^9]. The most intrigu-
ing feature of antimicrobial peptides is that they
rarely induce bacterial resistance [6], which has be-
come a serious problem with conventional antibiot-
ics. Therefore, antimicrobial peptides have emerged
as one of the most promising candidates for a new
class of antibiotics [10].
To date, the majority of these peptides have been
isolated from amphibians [11], insects [12], mammals
[13] and crustaceans [14]. A few antimicrobial pepti-
des have also been found in nematode [15] and ¢sh
[16]. However, very few have been reported in other
animal phyla, even though such molecules are likely
to be present widely throughout the animal kingdom.
In particular, antimicrobial peptides are likely to be
present in nearly all invertebrates because these ani-
mals do not produce speci¢c antibodies and therefore
need to rely on innate mechanisms for host protec-
tion against microbial attacks. In the 700 million
years of their existence, earthworms have evolved
in the environment replete with microorganisms,
some of which threatening their existence. To survive
in such an environment, they have developed e⁄cient
defense mechanisms against invading microorgan-
isms. Such defenses are present in the coelomic £uid
of earthworms, such as Lumbricus and Eisenia
[17,18]. The antimicrobial activity in the coelomic
£uid is attributed to some proteins, such as lysozyme
and fetidins [19^21]. So far, antimicrobial peptides
have not been reported in earthworms. In this study,
we report the puri¢cation, characterization and
cDNA cloning of a developmentally expressed anti-
microbial peptide (lumbricin I) from the earthworm,
Lumbricus rubellus, which exhibits antimicrobial ac-
tivity against Gram-negative, Gram-positive bacteria
and fungi without hemolytic activity.
2. Materials and methods
2.1. Peptide puri¢cation
An antimicrobial peptide was puri¢ed from the
earthworm, Lumbricus rubellus, as described previ-
ously by Park et al. [22]. Earthworms (200 g), which
were reared on an arti¢cial medium in a plastic con-
tainer, were homogenized using a Waring blender
(Waring, New Hartford, CT, USA) in 400 ml of
acidic medium consisting of 1% (v/v) tri£uoroacetic
acid (TFA), 1 M HCl, 5% (v/v) formic acid, 1% (w/v)
NaCl and pepstatin A at 1 Wg/ml. The homogenate
was centrifuged at 20 000Ug for 30 min in a Himac
SCR20BR (Hitachi, Tokyo, Japan) and the superna-
tant was collected. The peptides in the supernatant
were then subjected to reverse-phase concentration
using a Sep-Pak C18 cartridge (Millipore, Milford,
MA, USA) and separated on a 1.0U1.0 cm heparin
Sepharose column (Pharmacia, Uppsala, Sweden)
with a stepwise NaCl gradient of 0.1, 0.5 and 1 M.
All the fractions were then assayed for antimicrobial
activity against Bacillus subtilis. The active fractions
were pooled and further puri¢ed by high-perform-
ance liquid chromatography (HPLC) on a 3.9U
300 mm Delta Pak C18 column (Millipore) with a
linear gradient of 0^70% for 1 h at a £ow rate of
1 ml/min with bu¡er A (0.1% TFA in H2O) and
bu¡er B (0.1% TFA in acetonitrile). Each peak was
collected and assayed for antimicrobial activity as
before. The purity of the isolated peptide was as-
sessed by tricine SDS-PAGE and a matrix-associated
laser desorption ionization (MALDI) mass spectro-
scopy (Kratos Kompact MALDI, Manchester, UK).
2.2. Primary structure determination of the isolated
peptide
Molecular mass of the isolated peptide was deter-
mined by MALDI mass spectroscopy. Approxi-
mately 20 nmol of the lyophilized peptide was dis-
solved in 50% acetonitrile containing 7% (w/v)
sinapinic acid and mixed with a Pt probe. After re-
moving the solvent in warm air, the peptide, ad-
sorbed to the Pt probe, was applied to a vacuum
chamber and analyzed. Amino acid sequencing was
performed by the automated Edman degradation
method on an Applied Biosystem gas phase se-
quencer, Model 447 (Foster City, CA, USA). The
amount of peptide was determined by amino acid
analysis. The lyophilized peptide was hydrolyzed in
6 N HCl for 24 h at 110‡C and converted to its
phenylthiocarbamyl derivative. The sample was
then analyzed using a Pico-tag analysis system on a
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Beckman 121 MB amino acid analyzer (Fullerton,
CA, USA).
2.3. PCR ampli¢cation
Total RNA was extracted from the homogenized
earthworms by the guanidinium thiocyanate method
[23] and poly(A) mRNA was isolated from the total
RNA using a polyATtract mRNA isolation kit
(Promega, Madison, WI, USA). To prepare a pool
of cDNA, ¢rst strand cDNA was synthesized from
the poly(A) mRNA (5 Wg) using M-MLV reverse
transcriptase (Gibco BRL, Gaithersburg, MD, USA)
and the poly(dT) adapter primer 5P-GAGAGA-
GAGAGAGAGAGAGAACTAGTCTCGAG(T18)-
3P (olT, an XhoI site is underlined) at 37‡C. After 1 h,
the reaction was stopped by diluting 10 fold with
distilled water. Two primers, an adapter primer
(olA, 5P-GAGAGAGAACTAGTCTCGAG-3P) and
a degenerate primer (olD, 5P-AARTAYGAR MG-
NCARAARGA-3P encoding residues 3^9 of the iso-
lated peptide, where R = A,G; Y = C,T; M = A,C;
N = A,C,G,T), were used as primers in 3P-RACE
[24]. 3P-RACE was done in the bu¡er consisting of
10 mM Tris-HCl, pH 9.0, 1.5 mM MgCl2, 50 mM
KCl, 100 mM dNTPs, 25 pmol of each primer and
one-sixtieth of the cDNA pool prepared above. A
total of 30 ampli¢cation cycles were performed
with Taq polymerase. Each cycle consisted of 1 min
at 94‡C, 1 min at 55‡C and 1 min at 72‡C. To min-
imize the background and to increase the speci¢city
of the PCR reaction, the hot-start protocol was used
in which the addition of Taq polymerase was with-
held until the reaction temperature reached 80‡C. To
facilitate the cloning of PCR products, pBluescript II
SK was modi¢ed to a T-vector according to the
method of Marchuk et al. [25]. The PCR products
were cloned into the T-vector and then sequenced.
The 424-bp insert of a clone thus obtained was iso-
lated after EcoRI+HindIII restriction digestion and
labeled with [K-32P]dATP by the random priming
method [26] and then used as a probe for cDNA
library screening.
2.4. cDNA cloning and sequence analysis
A cDNA library was constructed with a Uni-ZAP
XR cDNA library kit (Stratagene, La Jolla, CA,
USA) according to the procedure provided by the
manufacturer. The double-stranded cDNA was size-
fractionated by agarose gel electrophoresis on a 1%
gel and fractions of 300^2000-bp DNA were recov-
ered by electroelution. The size-fractionated cDNA
was ligated into the Uni-ZAP XR vector and pack-
aged using a Gigapack II Gold packaging extract
(Stratagene). Approximately 5U106 independent
phages were obtained and 4U105 phages were plated
at a density of 5U104/150-mm plate on a loan of
Escherichia coli XL-1 Blue MRFP. Plaque lifts were
performed in duplicates using the Hybond N mem-
branes (Amersham, Buckinghamshire, UK) and
screened with the standard technique [26]. The mem-
branes were hybridized with the 32P-labeled probe
obtained from the 3P-RACE above in a solution con-
sisting of 50% formamide, 5USSC (1USSC: 15 mM
sodium citrate and 150 mM NaCl, pH 7.0), 1UDen-
hardt’s solution, 10% dextran sulfate, 100 mg/ml her-
ring sperm DNA and 0.1% SDS at 42‡C for 16 h.
The membranes were washed at room temperature,
twice in a solution containing 2USSC and 0.1% SDS
and once in a solution containing 0.2USSC and
0.1% SDS for 15 min each time. After the positive
clones had been plaque-puri¢ed, pBluescript vectors
containing the inserts were rescued by in vivo exci-
sion and sequenced. The nucleotide sequence was
determined by the dideoxy chain-termination method
[27] using a Sequenase version 2.0 kit (USB, Cleve-
land, OH, USA). All reaction steps were carried out
according to the protocols provided by the manufac-
turer. The nucleotide and amino acid sequences were
scanned and compared with databases available at
National Center for Biotechnology Information
(NCBI) of the National Institute of Health (NIH)
through the BLAST network service. A 29-amino
acid peptide in residues 6^34 of the isolated peptide,
which has a high sequence homology with other pro-
line-rich antimicrobial peptides, was synthesized at
Multiple Peptide Systems (San Diego, CA, USA).
The synthesized peptide was puri¢ed by reverse-
phase HPLC and the purity was con¢rmed by amino
acid analysis and MALDI mass spectroscopy.
2.5. Antimicrobial and hemolytic activity assay
Antimicrobial activity was examined during each
puri¢cation step by the radial di¡usion assay on B.
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subtilis lawn as described by Lehrer et al. [28]. A
20 ml of B. subtilis culture in the mid-logarithmic
phase was washed with cold 10 mM sodium phos-
phate bu¡er (NAPB), pH 7.4, and resuspended in
10 ml of cold NAPB. A cell suspension containing
1U106 bacterial colony forming units (CFUs) was
added to 6 ml of underlayer agar broth (10 mM
sodium phosphate, 1% (v/v) trypticase soy broth,
1% agarose, pH 6.5) and the mixture was poured
into a Petri dish. Samples were added directly to
3-mm-diameter wells which were made on the solidi-
¢ed underlayer agar. After incubation for 3 h at
37‡C, the underlayer agar was covered with a nu-
trient-rich top agar overlay and incubated overnight
at 37‡C. Antimicrobial activity was assayed by ob-
serving the zone of suppression of bacterial growth
around the 3-mm diameter wells. Minimal inhibitory
concentrations (MICs) of the isolated peptide against
several Gram-positive and Gram-negative bacteria
and fungi were determined by incubating approxi-
mately 104^105 CFU/ml of cells with serial dilutions
of the peptide in a 96-well microtiter plate (Nunc
F96 microtiter plates, Denmark) as described by
Moore et al. [29]. Bacterial (fungal) growth was as-
sessed by optical density measurement at 620 nm.
The lowest concentration of the peptide that showed
any suppression of bacterial (fungal) growth was
de¢ned MIC. Hemolytic activity of the antimicrobial
peptides was assayed as described by Park et al.
[16].
2.6. Northern blot analysis
Total RNA was extracted from eggs, 1-week and
6-month-old L. rubellus and two other annelid spe-
cies (Nereis japonica, a lugworm and Hirudo nippo-
nia, a leech). Total RNA was also extracted from the
6-month-old L. rubellus at regular time intervals after
bacterial challenge. Bacterial challenge was done by
injecting earthworms with 1 Wl of the diluted log-
phase culture of E. coli (1U107 CFU/ml), and the
earthworms were kept at room temperature for given
time intervals before RNA extraction. The total
RNA was fractionated by agarose gel electrophoresis
on a 1% agarose gel containing 6.7% formaldehyde
and 1UMOPS bu¡er (20 mM MOPS, 5 mM sodium
acetate and 1 mM Na2EDTA, pH 7.0) and blotted
onto the Hybond N membrane (Amersham) by the
capillary technique [26]. The insert of the full-length
cDNA clone, which was obtained by the cDNA li-
brary screening, was labeled with 32P using the ran-
dom priming method [26] and used as a probe for
Northern blot analysis. The membranes were hybrid-
ized with the 32P-labeled probe using the same
method described above in the cDNA cloning. Final
washing was carried out in a solution containing
0.2USSC and 0.1% SDS at 55‡C.
Fig. 1. Puri¢cation of lumbricin I. (A) Reverse-phase HPLC
chromatogram of the active fraction after heparin chromatogra-
phy. The active fraction was loaded on a 3.9U300 mm Delta-
pak C18 column and elution was achieved with a linear gra-
dient of acetonitrile in aqueous TFA (80% acetonitrile/0.1%
TFA). The peak containing lumbricin I is indicated by the ar-
row. (B) Mass spectroscopic analysis and tricine SDS-PAGE of
lumbricin I. Mass for lumbricin I (MH = 7231) was determined
by a MALDI mass spectrometer. The inset represents tricine
SDS-PAGE of lumbricin I. Lane M represents the molecular
mass size markers.
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3. Results
3.1. Puri¢cation and primary structure determination
of the antimicrobial peptide
Earthworms were homogenized in an acidic me-
dium and the acid extracts were fractionated on a
heparin-a⁄nity column. The active eluate was fur-
ther puri¢ed by reverse-phase HPLC (Fig. 1A).
Among several peaks, one which showed the stron-
gest antimicrobial activity was pooled and lyophi-
lized. The puri¢ed antimicrobial peptide was about
95% homogeneous, as con¢rmed by tricine SDS-
PAGE and MALDI mass spectroscopy (Fig. 1B),
and named lumbricin I (derived from the genus
name of the earthworm ‘Lumbricus’). The total
amount of puri¢ed lumbricin I recovered was 0.1 Wg
per g earthworm. The molecular mass of lumbricin I
was determined to be 7231 Da by MALDI mass
spectroscopy (Fig. 1B). This was in good agreement
Fig. 2. cDNA clone encoding lumbricin I. (A) Probe preparation for cDNA library screening using 3P-RACE. mRNA was reverse
transcribed using the poly(dT) adapter primer (olT). Ampli¢cation was performed using the adapter primer (olA) and the degenerate
primer (olD). The PCR fragment cloned into modi¢ed pBluescript II SK was used as a probe after being sequenced. See Section 2
for details. (B) Nucleotide and deduced amino acid sequences of cDNA encoding lumbricin I. The cloned cDNA was 555 bp in length
and contained an open reading frame of 231 bp. The lumbricin I precursor consisted of 76 amino acids, with 14 residues in a preseg-
ment (in italic). The arrow indicates the end of the putative signal sequence. The sequence of the mature lumbricin I is underlined.
The stop codon and the polyadenylation signal are marked with asterisks and a dotted line, respectively. The nucleotide sequence of
lumbricin I cDNA has been submitted to the GeneBank/EMBL sequence data bank with accession no. AF060552.
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with the mass calculated from the deduced amino
acid sequence of the cloned gene (Fig. 2B, underlined
region), which indicates that post-translational mod-
i¢cations were not present in lumbricin I. After ami-
no acid composition analysis, lumbricin I was then
subjected to amino acid sequence analysis by auto-
mated gas-phase sequencer. The sequence of lumbri-
cin I was determined up to the 22nd residue as Phe-
Ser-Lys-Tyr-Glu-Arg-Gln-Lys-Asp-Lys-Arg-Pro-Tyr-
Ser-Glu-Arg-Lys-Asn-Gln-Tyr-Thr-Gly.
3.2. cDNA cloning of lumbricin I
A cDNA library in the Uni-ZAP XR vector was
constructed using the mRNA extracted from L. ru-
bellus. PCR was used to facilitate the cDNA library
screening (Fig. 2A). By using poly(A) mRNA as a
template for 3P-RACE, a DNA fragment (Fig. 2B,
nucleotides 132^555) was ampli¢ed with the primers
(olD and olA) described in Section 2. The PCR frag-
ment was subcloned into the modi¢ed pBluescript II
SK, sequenced, and used as a probe for screening
the cDNA library by the plaque hybridization. Fif-
teen positive clones were isolated from approxi-
mately 400 000 transformants. Three clones contain-
ing largest cDNA inserts were selected and
sequenced. The nucleotide sequence of the clone car-
rying the largest cDNA insert (555 bp) is shown in
Fig. 2B.
3.3. Sequence analysis of cDNA
DNA sequence analysis of the 555-bp cDNA
showed that a 231-nucleotide-long open reading
frame started at nucleotide 84. The predicted start
codon was preceded by a 5P-untranslated region of
83 nucleotides. The 6-bp sequence £anking the puta-
tive translation start site at position 84 showed ho-
mology to the consensus sequence described by Ko-
zak [30]. A stop codon was found at nucleotide 312,
followed by a 3P-untranslated region of 221 nucleo-
tides. A typical polyadenylation signal was found at
nucleotide 514, 21 nucleotides upstream of the poly-
(A) tail. The open reading frame may be translated
into a 76-amino acid polypeptide. The predicted lum-
bricin I precursor started with a methionine residue
and its N-terminal sequence had a typical feature of
a signal peptide with a cluster of hydrophobic resi-
dues. The cleavage site for signal peptidase was most
likely after Thr14, considering the N-terminal amino
acid sequence of the native mature peptide deter-
mined by amino acid sequence analysis. After the
hydrophobic presegment of 14 amino acid residues,
the sequence corresponding to the mature peptide
was present in a single copy. The mature peptide
was relatively rich in proline (15% in molar ratio).
A computer search comparing the deduced amino
acid sequence of the cDNA with those of the protein
entries available at the NCBI showed that the N-
Table 1
Antimicrobial activity of lumbricin I, lumbricin I(6^34) and magainin 2
Microorganism (ATCC no.) Minimal inhibitory concentrations (Wg/ml)
Lumbricin I Lumbricin I(6^34) Magainin 2
Gram positive
Bacillus subtilis (62037) 12 8 50
Staphylococcus aureus (15752) 16 12 50
Streptococcus mutans (25175) 30 20 100
Gram negative
Escherichia coli (27325) 12 8 100
Pseudomonas putida (17426) 16 12 50
Serratia sp. (21074) 16 12 50
Fungi
Candida albicans (10231) 16 12 25
Cryptococcus neoformans (34881) 25 16 12
Saccharomyces cerevisiae (44774) 12 8 25
Minimal inhibitory concentrations were determined by incubating approximately 104^105 CFU/ml of cells with serial dilutions of each
peptide in a 96-well microtiter plate. Bacterial (fungal) growth was assessed by optical density measurement at 620 nm. The lowest
concentration of peptide that showed any suppression of bacterial (fungal) growth was de¢ned MIC.
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terminal portion of lumbricin I (residues 6^34) had a
considerable similarity with PR-39 and Bac5 (Fig. 3).
The region in the residues 6^34 of lumbricin I was
chemically synthesized and named lumbricin I(6^34).
3.4. Antimicrobial and hemolytic activity of the
isolated and synthetic peptides
Antimicrobial activity of lumbricin I and lumbri-
cin I(6^34) was determined against several microor-
ganisms, including Gram-positive, Gram-negative
bacteria and fungi. As shown in Table 1, lumbricin
I displayed antimicrobial activity against a broad
spectrum of bacteria, including B. subtilis ATCC
62037, Staphylococcus aureus ATCC 15752, Strepto-
coccus mutans ATCC 25175, E. coli ATCC 27325,
Pseudomonas putida ATCC 17426 and Serratia sp.
ATCC 21074. Furthermore, Candida albicans
ATCC 10231, Cryptococcus neoformance ATCC
34881 and Saccharomyces cerevisiae ATCC 44774
were also killed. And compared to magainin 2 [11],
puri¢ed from Xenopus laevis, lumbricin I was ap-
proximately three times more potent against tested
bacteria (Table 1). In addition, lumbricin I(6^34)
had marginally stronger antimicrobial activities
than lumbricin I. Any appreciable hemolytic activity
was not observed for both lumbricin I and lumbricin
I(6^34) (up to 100 Wg/ml) when tested against human
erythrocytes (Table 2).
3.5. Northern blot analysis
The expression pattern of the lumbricin I gene was
studied by Northern blot analysis. Northern blot in
Fig. 4 showed one mRNA band, whose size was
estimated to be about 0.7 kb. This indicates that
the sequence in Fig. 2B represents the full-length
cDNA, taking the length of the poly(A) tail into
account. To examine the inducibility of lumbricin I
gene upon bacterial infection, total RNA was ex-
tracted at regular time intervals from bacteria-non-
challenged and bacteria-challenged L. rubellus and
analyzed by Northern blot (Fig. 4A). The Northern
blot result showed that lumbricin I mRNA was
present both in bacteria-non-challenged and bacte-
ria-challenged ones. When total RNA was isolated
from L. rubellus at various developmental stages
and analyzed by Northern blot, lumbricin I mRNA
was not detected in eggs and 1-week-old L. rubellus,
but was abundant in 6-month-old L. rubellus (Fig.
4B). Also, lumbricin I mRNA was not detected in
the two other annelid species, N. japonica and
Table 2
Hemolytic activity of lumbricin I, lumbricin I(6^34) and melittin
Concentrations (Wg/ml) % Hemolysis of human erythrocytes
Lumbricin I Lumbricin I(6^34) Melittin
0 0.00 0.00 0.00
5 0.02 0.03 17.20
10 0.06 0.07 45.21
25 0.14 0.13 63.83
50 0.19 0.17 90.03
100 0.23 0.21 99.10
Hemolytic activity of each peptide was determined using human erythrocytes. The release of hemoglobin was monitored by measuring
the optical density at 576 nm. The relative optical density, as compared with that of the cell suspension treated with 0.1% Triton X-
100, was de¢ned % hemolysis.
Fig. 3. Sequence comparison of lumbricin I(6^34) with other members of proline-rich antimicrobial peptide. The region in the residues
6^34 of lumbricin I, which was named as lumbricin I(6^34), was aligned with the sequences of PR-39 and Bac5. Sequences were
aligned using the CLUSTAL W program with default parameters. In aligning sequences, breaks are introduced to optimize the simi-
larity. Residues identical in two or more sequences are boxed.
BBADIS 61762 8-10-98
J.H. Cho et al. / Biochimica et Biophysica Acta 1408 (1998) 67^76 73
H. nipponia (Fig. 4C, lanes 2 and 3), which indicated
that lumbricin I might be unique in L. rubellus.
4. Discussion
Antimicrobial peptides, which are now considered
as one of universal host defense tools of living or-
ganisms against microbial infection [31], have been
found in both vertebrates and invertebrates. Most of
antimicrobial peptides so far found in invertebrate
were from insects [12], crustaceans [14] and nemato-
des [15]. We describe here the puri¢cation, character-
ization and cDNA cloning of a novel proline-rich
antimicrobial peptide from the earthworm (L. rubel-
lus), which showed antimicrobial activity against a
broad range of microorganisms. This is one of the
¢rst reports on the annelid antimicrobial peptide
which does not possess any hemolytic activity.
The most remarkable feature of lumbricin I was its
high content of proline (15% in molar ratio). Proline
confers unique conformational constraints on the
peptide chain in that the side-chain is cyclized back
onto the backbone amide position [32]. The high
contents of proline may have undoubtedly a major
in£uence on the secondary structure of lumbricin I
and hence on its mode of action. CD spectra analysis
(data not shown) revealed that lumbricin I had a
rather random structure even in 50% tri£uoroethanol
instead of an amphiphilic K-helical conformation
common for other antimicrobial peptides, such as
maganins [11], cecropins [33] and buforins [22]. Pro-
line richness is not an uncommon characteristic of
antimicrobial peptides. Many proline-rich antimicro-
bial peptides were discovered from various sources.
Apidaecins [34], drosocin [35], metchnikowin [36],
bactenecins [37] and PR-39 [38] belong to this group.
They have the common characteristics of high con-
tents of proline and positively charged amino acids,
but their antimicrobial spectra and mode of action
are quite di¡erent from one another. Apidaecins,
bactenecins and PR-39 kill only Gram-negative bac-
teria. Drosocin kills both Gram-positive and Gram-
negative bacteria, but is inactive against fungi.
Metchnikowin is active against Gram-positive bacte-
ria and fungi, but inactive against Gram-negative
bacteria. In the case of apidaecins, they exert anti-
bacterial activity through a non-pore-forming mech-
anism involving stereospeci¢city [39]. Bactenecins in-
crease the membrane permeability, causing the loss
of cellular metabolites [40], and PR-39 was known to
arrest protein and DNA synthesis in cells [8,9]. The
exact action mode of lumbricin I is not understood
at present. However, its broad activity spectrum sug-
gests that its mechanism of action is di¡erent from
that of other members of the proline-rich peptide
family. The overall positive charge of lumbricin I is
only +1 (10 positively charged amino acids, 9 nega-
Fig. 4. Northern blot analysis of lumbricin I mRNA. (A) Expression pro¢les of lumbricin I gene upon bacterial infection. RNA was
extracted at regular time intervals (as indicated on the top of the gel) after the injection of bacteria. RNA (20 Wg each) was separated
on a 1.0% agarose gel containing formaldehyde, blotted on a Hybond N membrane, and hybridized with the 32P-labeled cDNA in-
sert. (B) Expression of the lumbricin I gene during development. RNA (20 Wg each) was extracted from egg (lane 1), 1-week-old (lane
2) and 6-month-old L. rubellus (lane 3) and analyzed by Northern blot hybridization. (C) Comparison with two other annelid species.
RNA (20 Wg each) was extracted from L. rubellus (lane 1), N. japonica (lane 2) and H. nipponia (lane 3) and analyzed by Northern
blot hybridization. The size of lumbricin I mRNA was estimated by using EtBr-stained RNA size markers. The positions of RNA
size markers (in kb) are shown on the left (A) or in the middle of the two gels (B,C).
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tively charged amino acids), which is very low as
compared to that of other antimicrobial peptides. It
seems that the net positive charge alone does not
account for the antimicrobial activity of lumbricin
I, and other structural features, such as secondary
structure, might be as important as the net positive
charge. It was reported that the important factors in
the activity of antimicrobial peptides include the po-
sition and nature of positively charged residues, the
formation of speci¢c secondary structures and the
creation of hydrophobic face on the molecule [41].
The expression pro¢les of the lumbricin I gene in
the earthworm were studied by Northern blot anal-
ysis (Fig. 4). A time course study performed on 6-
month-old adult L. rubellus, which was challenged by
the inoculation of a low dose of bacteria, showed
that the expression of lumbricin I gene was not in-
ducible upon bacterial infection. Instead, lumbricin I
gene was constitutively expressed (Fig. 4A). North-
ern blot analysis also showed that lumbricin I
mRNA was present only in 6-month-old adult L.
rubellus, but not in egg and 1-week-old young L.
rubellus (Fig. 4B), which suggests that the expression
of the lumbricin I gene might be speci¢c in adult L.
rubellus. The lack of lumbricin I expression in eggs
and young earthworms implies that other protection
mechanisms may take the place of lumbricin I in
them. In fact, the earthworm egg is enveloped by
the passive structural barrier, cocoon, whose wall is
made of chitin-like material, and all the development
of earthworm takes place within the cocoon [42].
When total RNA was extracted from other annelid
species, such as N. japonica and H. nipponia, and
blotted with 32P-labeled lumbricin I cDNA, lumbri-
cin I mRNA was not detected (Fig. 4C). This indi-
cates that lumbricin I is unique in L. rubellus.
Even though we did not con¢rm the actual bio-
logical role of lumbricin I in vivo, our results indicate
that lumbricin I, which is present only in adult L.
rubellus, may serve as a component of the defense
system of earthworms. Future works will focus on
the elucidation of the cellular localization and the
biological role of lumbricin I in vivo.
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